Announcement Released Wed-25th-November-2015 11:31 GMT
Contact: A*STAR Research Institution: The Agency for Science, Technology and Research (A*STAR)
Singapore's IBN Executive Director Professor Jackie Y. Ying Elected Fellow of the American Association for the Advancement of Science

Professor Jackie Y. Ying, Executive Director of the Institute of Bioengineering and Nanotechnology of Agency for Science, Technology and Research in Singapore has been named a Fellow of the American Association for the Advancement of Science (AAAS).

Singapore, November 25, 2015 – Professor Jackie Y. Ying, Executive Director of the Institute of Bioengineering and Nanotechnology (IBN) of Agency for Science, Technology and Research (A*STAR) has been named a Fellow of the American Association for the Advancement of Science (AAAS). Prof Ying was nominated by her peers for her distinguished contributions to the fields of nanotechnology and bioengineering, particularly for the design and synthesis of nanomaterials and nanodevices for biomedical and catalytic applications.

“I am honored to be elected as a Fellow of the AAAS, which has made major contributions in its mission to advance science and serve society. My lab has focused on establishing nanotechnology as a tool box with unique properties and functionalities to tackle various scientific challenges. We hope that the new biomedical and green chemistry breakthroughs would have a significant impact on society,” said Prof Ying.

This year 347 members have been awarded the distinction of Fellow by the American Association for the Advancement of Science because of their scientifically or socially distinguished efforts to advance science or its applications. New Fellows will be inducted at their 2016 Annual Meeting in Washington, D.C on February 13, 2016.

“Election as a Fellow of the AAAS recognizes Jackie Ying's remarkable contributions to nanotechnology. She has repeatedly demonstrated a unique ability to select an important societal problem, design a material at the molecular and supra-molecular levels in order to address that problem, and finally to actually synthesize that material and demonstrate that it exhibits the requisite properties to solve the problem,” said Professor Kenneth A. Smith, Chair of the IBN Scientific Advisory Board and Edwin R. Gilliland Professor of Chemical Engineering (Emeritus) at the Massachusetts Institute of Technology.

“Jackie Ying has taken to a new level a total-system understanding and application of materials chemistry. She has made exceptional and creative contributions to the basic science and engineering concepts needed to cost-effectively synthesize nanoporous materials, nanocomposite materials, biomaterials and biosystems. The impact of the innovative basic science and engineering synthesis pathways that she has developed is amplified by their translation into commercially applied up-scaling and new process engineering concepts. Of equal significance is the outreach role that she has played as a mentor and model for aspiring professional students and scientists. I am delighted that her contributions have been recognized by the AAAS,” said Professor Galen D. Stucky, Co-Chair of the IBN Scientific Advisory Board and Professor of Chemistry and Biochemistry, and of Materials at the University of California, Santa Barbara.

Prof Ying’s research is interdisciplinary in nature. Her laboratory has created novel nanoporous materials, nanocomposites, and nanodevices. These new systems are designed for applications ranging from pharmaceuticals synthesis, green chemistry, energy storage, to nanomedicine, drug delivery systems, cell and tissue engineering, biosensors and medical diagnostics.

Prof Ying has authored over 340 articles with a h index of 64, and presented over 400 invited lectures at international conferences. She has over 150 primary patents issued or pending, and has served on the Advisory Boards of 7 start-up companies and 2 venture capital funds. Prof Ying is Editor-in-Chief of the journal, Nano Today, which has an impact factor of 15.000.

The AAAS is the world’s largest general scientific society, and publisher of the leading journal, Science, as well as Science Translational Medicine and Science Signaling. The association was founded in 1848, and includes 254 affiliated societies and academies of science, serving 10 million individuals.


Media Contacts:

Elena Tan
Phone: +65 6824 7032

Nidyah Sani
Phone: +65 6824 7005

About the Institute of Bioengineering and Nanotechnology (IBN)

The Institute of Bioengineering and Nanotechnology (IBN) is the world’s first bioengineering and nanotechnology research institute. Established in 2003, IBN’s mission is to conduct multidisciplinary research across science, engineering, and medicine for breakthroughs to improve healthcare and quality of life. IBN’s research activities are focused on Nanomedicine, Synthetic Biosystems, Biodevices and Diagnostics, and Green Chemistry and Energy. The Institute has published over 1,000 papers in leading scientific journals, filed over 300 active patents and patent applications on its inventions, and established 9 spin-off companies. To nurture young research talents, IBN runs a Youth Research Program that offers students research attachment opportunities and exposure to biomedical research. For more information, please visit

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society.

As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by contributing to societal benefits such as improving outcomes in healthcare, urban living, and sustainability.

We play a key role in nurturing and developing a diversity of talent and leaders in our Agency and Research Institutes, the wider research community and industry. A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities primarily located in Biopolis and Fusionopolis.

For more information on A*STAR, please

Associated websites:

Create Account...